Zeng B-Y, Heales S J R, Canevari L, Rose S, Jenner P
Neurodegenerative Disease Research Centre, GKT School of Biomedical Sciences, King's College, London SE1 1UL, UK.
Exp Neurol. 2004 Dec;190(2):515-24. doi: 10.1016/j.expneurol.2004.08.022.
The hph-1 mice have defective tetrahydrobiopterin biosynthesis and share many neurochemical similarities with l-dopa-responsive dystonia (DRD) in humans. In both, there are deficiencies in GTP cyclohydrolase I and low brain levels of dopamine (DA). Striatal tyrosine hydroxylase (TH) levels are decreased while the number of DA neurones in substantia nigra (SN) appears normal. The hph-1 mouse is therefore a useful model in which to investigate the biochemical mechanisms underlying dystonia in DRD. In the present study, the density of striatal DA terminals and DA receptors and the expression of D-1, D-2, and D-3 receptors, preproenkephalin (PPE-A), preprotachykinin (PPT), and nitric oxide synthase (NOS) mRNAs in the striatum and nucleus accumbens and nigral TH mRNA expression were examined. Striatal DA terminal density as judged by specific [3H]mazindol binding was not altered while the levels of TH mRNA were elevated in the SN of hph-1 mice compared to control (C57BL) mice. Total and subregional analysis of the striatum and nucleus accumbens showed that D-2 receptor ([3H]spiperone) binding density was increased while D-1 receptor ([3H]SCH 23390) and D-3 receptor ([3H]7-OH-DPAT) binding density was not altered. In the striatum and nucleus accumbens, expression of PPT mRNA was elevated but PPE-A mRNA, D-1, D-2 receptor, and nNOS mRNA were not changed in hph-1 mice compared to controls. These findings suggest that an imbalance between the direct strionigral and indirect striopallidal output pathways may be relevant to the genesis of DRD. However, the pattern of changes observed is not that expected as a result of striatal dopamine deficiency and suggests that other effects of GTP cyclohydrolase I deficiency may be involved.
hph-1小鼠的四氢生物蝶呤生物合成存在缺陷,并且在神经化学方面与人类的左旋多巴反应性肌张力障碍(DRD)有许多相似之处。在这两种情况中,鸟苷三磷酸环化水解酶I均存在缺陷,且脑内多巴胺(DA)水平较低。纹状体酪氨酸羟化酶(TH)水平降低,而黑质(SN)中DA神经元的数量似乎正常。因此,hph-1小鼠是研究DRD中肌张力障碍潜在生化机制的有用模型。在本研究中,检测了纹状体DA终末和DA受体的密度,以及纹状体和伏隔核中D-1、D-2和D-3受体、前脑啡肽原(PPE-A)、前速激肽原(PPT)和一氧化氮合酶(NOS)mRNA的表达,以及黑质TH mRNA的表达。通过特异性[3H]麦角乙脲结合判断的纹状体DA终末密度未改变,而与对照(C57BL)小鼠相比,hph-1小鼠黑质中TH mRNA水平升高。对纹状体和伏隔核的整体及分区分析表明,D-2受体([3H]螺哌隆)结合密度增加,而D-1受体([3H]SCH 23390)和D-3受体([3H]7-羟基-DPAT)结合密度未改变。在纹状体和伏隔核中,与对照相比,hph-1小鼠中PPT mRNA的表达升高,但PPE-A mRNA、D-1、D-2受体和nNOS mRNA未改变。这些发现表明,直接的纹状体黑质和间接的纹状体苍白球输出通路之间的失衡可能与DRD的发生有关。然而,观察到的变化模式并非纹状体多巴胺缺乏所预期的,这表明可能涉及鸟苷三磷酸环化水解酶I缺乏的其他影响。